FDA Focus: What Loeb & Loeb's Practice Chair Is Watching
By Jeff Overley · October 23, 2018, 6:59 PM EDT
Scott Liebman, head of the U.S. Food and Drug Administration practice at Loeb & Loeb LLP, tells Law360 that he's watching drugmakers loosen up on social media, tracking a high-stakes patent...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login